HOME >> BIOLOGY >> NEWS
Salamanders suffer delayed effects of common herbicide

razine exposure paled in comparison to the persistent effects of atrazine that continued to cause mortality after exposure ceased, said researchers. Compared to salamanders not exposed to atrazine, survivors of the atrazine exposure had significantly lower survival 421 days after being exposed. In other words, effects of early exposure to the chemical were showing up over the long term, such that the net effect of atrazine exposure was even worse later in life than it was while the animals were being exposed.

"The biggest surprise was that it took nearly a year to detect the effects of atrazine at 4 parts per billion, which is just 1 part per billion above the maximum allowable level in drinking water set by the U.S Environmental Protection Agency," said Rohr, who presented his findings at a recent workshop organized by the U.S Geological Survey in St. Louis, Missouri.

"What this tells me is that we need to consider the long-term effects of chemicals, and that exposure to atrazine during formative stages might have permanent effects on these salamanders that increases their risk of mortality," he added.

While the mechanism by which atrazine causes elevated mortality remains unclear, Rohr says other scientists have evidence suggesting that this pesticide is an endocrine disruptor.

Such chemicals disrupt the production of hormones that are vital to normal bodily functions. Concentrations of atrazine as low as 0.1 parts per billion have been shown to cause male frogs to develop both male and female organs by altering their production of sex hormones.

Findings from Rohr's study, which was funded by the U.S Environmental Protection Agency, National Science Foundation, and the Kentucky Academy of Sciences, could have implications for global amphibian declines.

"Salamanders, and amphibians in general, are crucial to ecosystems, as both predators and prey. They can be seen as bioindicators of environmental stress and harbingers of risk
'"/>

Contact: Amitabh Avasthi
axa47@psu.edu
814-865-9481
Penn State
23-Mar-2007


Page: 1 2 3

Related biology news :

1. Better sleep may put Huntingtons disease sufferers back on track
2. Male or female factor infertility -- men suffer just the same
3. New treatment increases life time expectancy of patients suffering from advanced liver cancer
4. Coarse particulate matter in air may harm hearts of asthma sufferers, UNC study finds
5. Vaccine hope for sufferers of potentially fatal stomach bug
6. Swell gel could bring relief to back pain sufferers
7. How fish species suffer as a result of warmer waters
8. Wolves are suffering less from inbreeding than expected
9. Hope remains for Alzheimers sufferers
10. New biologic treatment for tennis elbow may replace surgery for chronic sufferers
11. Children of allergy sufferers prone to same problem

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Salamanders suffer delayed effects common herbicide

(Date:12/19/2014)... VEGAS , Dec. 18, 2014   LaunchKey , ... for the post-password and Internet of Things era, today ... funding. The venture round was led by Metamorphic Ventures ... Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has raised ...
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 16, 2014 Valencell, ... licensed its PerformTek biometric technology to industry leaders such ... highly accurate, clinically validated, biometric wearable products. These products ... 6-9 in Las Vegas . ...
(Date:12/11/2014)... and Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... the addition of the "Biometrics Market in the ... One major trend emerging in this market is ... is important to upgrade biometric solutions to the latest ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:1/22/2015)... The laboratory information management systems market is ... of technological advancements due to factors such as rising ... integrate healthcare systems, and increasing government support for adoption ... Key players in the market focus on technological advancements ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited ... seminar on probiotics in San Diego, CA. , The ... for health care professionals. This year’s pre-conference seminar was held ... health. Dr. Leyer spoke about the emerging topics and science ...
(Date:1/22/2015)... Jan. 22, 2015   Cypher Genomics, Inc., ... (NASDAQ: SQNM ), the leading molecular ... next generation noninvasive prenatal tests (NIPT). Through this ... called Mantis™, to advance analysis of clinically-relevant fetal ...
(Date:12/24/2014)... Md. , Dec. 24, 2014  United Therapeutics Corporation ... Inc. (NYSE: MDT ) has submitted a ... Administration (FDA) for the use of Medtronic,s SynchroMed ® ... developed catheter) for use with United Therapeutics, Remodulin ® ...
Breaking Biology Technology:Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
Cached News: